Acorda Therapeutics
ACOR
#11224
Rank
S$1.05 M
Marketcap
S$0.85
Share price
0.00%
Change (1 day)
-95.70%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -S$0.36 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are S$0.11 Billion. In 2023 the company made an earning of -S$0.34 Billion a decrease over its 2022 earnings that were of -S$6.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.36 Billion6.27%
2023 -S$0.34 Billion4848.63%
2022 -S$6.84 Million-93.25%
2021 -S$0.11 Billion2.52%
2020 -S$98.77 Million-69.45%
2019 -S$0.33 Billion-700.62%
2018 S$53.83 M-118.02%
2017 -S$0.3 Billion805.99%
2016 -S$32.98 Million-173.88%
2015 S$44.63 M-6.58%
2014 S$47.78 M20.19%
2013 S$39.75 M18.7%
2012 S$33.49 M-26.54%
2011 S$45.59 M
2009 -S$0.11 Billion10.65%
2008 -S$94.09 Million86.17%
2007 -S$50.54 Million68.1%
2006 -S$30.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-S$0.17 Billion-51.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$95.19 M-127.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-S$97.98 Million-71.86%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
S$0.19 B-154.87%๐Ÿ‡บ๐Ÿ‡ธ USA